|
VPS36 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62492241884138E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.42028619368284E-14 |
| Normal-vs-Stage2 |
2.18029999998759E-06 |
| Normal-vs-Stage3 |
8.88178419700125E-15 |
| Normal-vs-Stage4 |
1.29569688311904E-11 |
| Stage1-vs-Stage2 |
4.842000E-01 |
| Stage1-vs-Stage3 |
4.292400E-02 |
| Stage1-vs-Stage4 |
1.244650E-01 |
| Stage2-vs-Stage3 |
6.229800E-02 |
| Stage2-vs-Stage4 |
1.123580E-01 |
| Stage3-vs-Stage4 |
9.888200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
6.33300000000281E-05 |
| Normal-vs-Asian |
2.31679999629364E-08 |
| Caucasian-vs-AfricanAmerican |
2.023600E-01 |
| Caucasian-vs-Asian |
3.233800E-01 |
| AfricanAmerican-vs-Asian |
6.572200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.89670542897147E-13 |
| Normal-vs-Female |
1.62547753035369E-12 |
| Male-vs-Female |
5.465600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.90558679946662E-12 |
| Normal-vs-Age(41-60Yrs) |
3.05311331771918E-14 |
| Normal-vs-Age(61-80Yrs) |
1.91510141078766E-11 |
| Normal-vs-Age(81-100Yrs) |
1.562700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.626800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.883600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.112000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.422400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.789000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.746800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.030800E-01 |
| Classical-VS-Follicular |
1.292010E-01 |
| Classical-VS-Other |
3.190000E-01 |
| Classical-VS-Normal |
1.6251444634463E-12 |
| Tall-VS-Follicular |
2.284300E-02 |
| Tall-VS-Other |
7.010800E-01 |
| Tall-VS-Normal |
1.773099445046E-10 |
| Follicular-VS-Other |
2.110400E-01 |
| Follicular-VS-Normal |
1.13130000001238E-06 |
| Other-VS-Normal |
2.228000E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.44244682443696E-13 |
| Normal-vs-N1 |
6.06703576266909E-12 |
| N0-vs-N1 |
2.922600E-01 |
|
|
